e-learning
resources
Vienna 2012
Monday, 03.09.2012
Novel approaches to lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles
E. Cova, M. Colombo, M. Morosini, S. Miserere, S. Inghilleri, S. Magni, D. Prosperi, F. Meloni (Pavia, Milan, Italy)
Source:
Annual Congress 2012 - Novel approaches to lung transplantation
Session:
Novel approaches to lung transplantation
Session type:
Oral Presentation
Number:
1854
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Cova, M. Colombo, M. Morosini, S. Miserere, S. Inghilleri, S. Magni, D. Prosperi, F. Meloni (Pavia, Milan, Italy). LATE-BREAKING ABSTRACT: Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles. Eur Respir J 2012; 40: Suppl. 56, 1854
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Related content which might interest you:
Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalation
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015
Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells
Source: ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018
Year: 2019
Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
LATE-BREAKING ABSTRACT: Autophagic induction by graphene oxide and its reductives in pulmonary epithelial cells
Source: Annual Congress 2013 –New molecular and cell biology mechanisms
Year: 2013
Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019
Mesenchymal stromal cells and macrophages in sepsis: new insights
Source: Eur Respir J, 51 (4) 1800510; 10.1183/13993003.00510-2018
Year: 2018
Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
Mesenchymal stem cells and fibrotic lung diseases
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014
Mesenchymal stem cells and their potential for clinical use
Source: Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung
Year: 2004
Cell-derived microparticles and the lung
Source: Eur Respir Rev 2016; 25: 266-277
Year: 2016
Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
YI05 - Mesenchymal stromal cells identified in tissue from lung-transplanted patients
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
Mesenchymal stromal cells in clinical trials: implications for emphysema
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
LATE-BREAKING ABSTRACT: Anti-fibrotic effects of nintedanib and pirfenidone in 2D versus 3D lung cultures
Source: International Congress 2016 – IPF pathogenesis
Year: 2016
Imaging of the interaction of fine particles and nanoparticles with lung cells
Source: Annual Congress 2009 - WS1 - New imaging methods for the researcher: believe what you see!
Year: 2009
LATE-BREAKING ABSTRACT: Tissue-resident epithelial stem/progenitor cells in pulmonary epithelial repair
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept